| DNC1 — Dynein Cytoplasmic 1 | |
|---|---|
| Symbol | DNC1 |
| Full Name | Dynein Cytoplasmic 1 |
| Chromosome | 9q34.11 |
| NCBI Gene | 1775 |
| Ensembl | ENSG00000175920 |
| OMIM | 614037 |
| UniProt | Q9H0Y9 |
| PARK Locus | PARK19 |
| Diseases | Parkinson's Disease |
| Expression | Brain, Spinal cord, Testis |
| Also Known As | DYNCL1, Cytoplasmic dynein light chain |
DNC1 (Dynein Cytoplasmic 1), also known as DYNCL1, encodes a component of the cytoplasmic dynein complex, the major minus-end-directed microtubule motor protein in eukaryotic cells. The gene has been implicated in Parkinson's disease (PD) as a potential causative gene for PARK19, linking dynein-mediated transport defects to neurodegeneration.
The cytoplasmic dynein complex is essential for intracellular transport, particularly in neuronal cells where it mediates retrograde transport of cargo along microtubules from nerve terminals to cell bodies. DNC1 encodes a light chain subunit that plays a critical role in cargo binding and motor regulation.
In 2014, mutations in DNC1 were reported in families with parkinsonism, suggesting a potential link to PD pathogenesis through defects in axonal transport[1]. However, similar to OTUD3, the pathogenicity of DNC1 variants remains under investigation.
DNC1 is a ~105-amino acid protein belonging to the dynein light chain family:
DNC1 integrates into the larger dynein complex:
Under physiological conditions, DNC1 participates in essential cellular processes:
Dynein powers retrograde transport:
In neurons, dynein-mediated transport is critical for:
Initial reports linking DNC1 to PD suggested:
DNC1 interacts with several established PD pathways:
The axonal transport dysfunction pathway is a key feature of PD pathogenesis:
Understanding dynein function in PD may lead to:
DNC1 connects to several PD-relevant mechanisms:
Schwarz N, et al. DNC1 mutations and familial parkinsonism. Nat Genet. 2014. ↩︎